Search Results

There are 6264 results for: content related to: DNA-Controlled Bivalent Presentation of Ligands for the Estrogen Receptor

  1. Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 5, May 2011, Pages: 708–717, TE Mürdter, W Schroth, L Bacchus-Gerybadze, S Winter, G Heinkele, W Simon, PA Fasching, T Fehm, The German Tamoxifen and AI Clinicians Group, M Eichelbaum, M Schwab and H Brauch

    Article first published online : 30 MAR 2011, DOI: 10.1038/clpt.2011.27

  2. You have free access to this content
    Effects of anti-oestrogens and β-estradiol on calcium uptake by cardiac sarcoplasmic reticulum

    British Journal of Pharmacology

    Volume 132, Issue 7, April 2001, Pages: 1374–1382, Marnie L Dodds, Margaret E Kargacin and Gary J Kargacin

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703924

  3. A role for plakophilin-1 in the initiation of desmosome assembly

    Journal of Cellular Biochemistry

    Volume 96, Issue 2, 1 October 2005, Pages: 390–403, James K. Wahl III

    Article first published online : 29 JUN 2005, DOI: 10.1002/jcb.20514

  4. DNA-gesteuerte bivalente Präsentation von Liganden für den Östrogenrezeptor

    Angewandte Chemie

    Volume 123, Issue 37, September 5, 2011, Pages: 8751–8755, Frank Abendroth, Alexander Bujotzek, Min Shan, Prof. Dr. Rainer Haag, Dr. Marcus Weber and Prof. Dr. Oliver Seitz

    Article first published online : 26 JUL 2011, DOI: 10.1002/ange.201101655

  5. Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone-Dependent and Hormone-Independent Breast Cancer Cell Lines

    Chemistry - A European Journal

    Volume 9, Issue 21, November 7, 2003, Pages: 5223–5236, Siden Top, Anne Vessières, Guy Leclercq, Jacques Quivy, J. Tang, J. Vaissermann, Michel Huché and Gérard Jaouen

    Article first published online : 10 OCT 2003, DOI: 10.1002/chem.200305024

  6. You have full text access to this Open Access content
    Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer

    Cancer Science

    Volume 102, Issue 11, November 2011, Pages: 2038–2042, Hirokuni Ikeda, Naruto Taira, Tomohiro Nogami, Kazuhiko Shien, Masanori Okada, Tadahiko Shien, Hiroyoshi Doihara and Shinichiro Miyoshi

    Article first published online : 1 SEP 2011, DOI: 10.1111/j.1349-7006.2011.02050.x

  7. Ab initio studies of tamoxifen and related compounds

    International Journal of Quantum Chemistry

    Volume 96, Issue 4, 2004, Pages: 374–379, Ming-Ju Huang

    Article first published online : 13 AUG 2003, DOI: 10.1002/qua.10731

  8. High Affinity Fluorescent Ligands for the Estrogen Receptor

    European Journal of Organic Chemistry

    Volume 2015, Issue 10, April 2015, Pages: 2157–2166, Frank Abendroth, Marthe Solleder, Dorothea Mangoldt, Pia Welker, Kai Licha, Marcus Weber and Oliver Seitz

    Article first published online : 19 FEB 2015, DOI: 10.1002/ejoc.201403489

  9. Reduced Bioavailability of Tamoxifen and its Metabolite 4-Hydroxytamoxifen After Oral Administration with Biochanin A (an Isoflavone) in Rats

    Phytotherapy Research

    Volume 26, Issue 2, February 2012, Pages: 303–307, Sheelendra Pratap Singh, Wahajuddin, K. S. R. Raju, Mushir M. Ali, Kanchan Kohli and Girish Kumar Jain

    Article first published online : 1 DEC 2011, DOI: 10.1002/ptr.3652

  10. Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry

    Rapid Communications in Mass Spectrometry

    Volume 24, Issue 6, 30 March 2010, Pages: 749–760, Monica Mazzarino, Xavier de la Torre, Roberto Di Santo, Ilaria Fiacco, Federica Rosi and Francesco Botrè

    Article first published online : 24 FEB 2010, DOI: 10.1002/rcm.4432

  11. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen–hydroxybutenyl-β-cyclodextrin formulations

    Journal of Pharmaceutical Sciences

    Volume 96, Issue 3, March 2007, Pages: 644–660, Charles M. Buchanan, Norma L. Buchanan, Kevin J. Edgar, James L. Little, Michael O. Malcolm, Karen M. Ruble, Vincent J. Wacher and Michael F. Wempe

    Article first published online : 2 NOV 2006, DOI: 10.1002/jps.20709

  12. Antiestrogenic Regulation of Transforming Growth Factor Beta Receptors I and II in Human Breast Cancer Cells

    Annals of the New York Academy of Sciences

    Volume 963, Issue 1, June 2002, Pages: 140–143, M. BUCK, J. VON DER FECHT and C. KNABBE

    Article first published online : 24 JAN 2006, DOI: 10.1111/j.1749-6632.2002.tb04104.x

  13. Detektion ligandeninduzierter Konformationsänderungen im Östrogenrezeptor

    Angewandte Chemie

    Volume 127, Issue 14, March 27, 2015, Pages: 4454–4457, Svenja C. Mayer-Wrangowski and Prof. Dr. Daniel Rauh

    Article first published online : 9 FEB 2015, DOI: 10.1002/ange.201410148

  14. Monitoring Ligand-Induced Conformational Changes for the Identification of Estrogen Receptor Agonists and Antagonists

    Angewandte Chemie International Edition

    Volume 54, Issue 14, March 27, 2015, Pages: 4379–4382, Svenja C. Mayer-Wrangowski and Prof. Dr. Daniel Rauh

    Article first published online : 9 FEB 2015, DOI: 10.1002/anie.201410148

  15. Effects of herbal supplements on the bioactivation of chemotherapeutic agents

    Journal of Pharmacy and Pharmacology

    Volume 65, Issue 7, July 2013, Pages: 1014–1025, Gregory S. Gorman, Lori Coward, Adrienne Darby and Bethany Rasberry

    Article first published online : 25 MAR 2013, DOI: 10.1111/jphp.12055

  16. Role and Clinical Consequences of Human UDP-Glucuronosyltransferases

    Standard Article

    Encyclopedia of Drug Metabolism and Interactions

    Deepak K. Dalvie and Cho-Ming Loi

    Published Online : 31 JAN 2012, DOI: 10.1002/9780470921920.edm122

  17. Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour

    ChemBioChem

    Volume 4, Issue 8, August 4, 2003, Pages: 754–761, Siden Top, El Bachir Kaloun, Anne Vessières, Guy Leclercq, Ioanna Laïos, Michèle Ourevitch, Christine Deuschel, Michael J. McGlinchey and Gérard Jaouen

    Article first published online : 28 JUL 2003, DOI: 10.1002/cbic.200200550

  18. You have free access to this content
    p53 polymorphic variants at codon 72 exert different effects on cell cycle progression

    International Journal of Cancer

    Volume 108, Issue 2, 10 January 2004, Pages: 196–199, David Pim and Lawrence Banks

    Article first published online : 27 OCT 2003, DOI: 10.1002/ijc.11548

  19. You have free access to this content
    Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells

    European Journal of Immunology

    Volume 31, Issue 9, September 2001, Pages: 2623–2632, Min Li-Weber, Marco Giaisi, Katerina Chlichlia, Khashayarsha Khazaie and Peter H. Krammer

    Article first published online : 24 AUG 2001, DOI: 10.1002/1521-4141(200109)31:9<2623::AID-IMMU2623>3.0.CO;2-4

  20. Determination of 4-hydroxytamoxifen in mouse plasma in the pg/mL range by gradient capillary liquid chromatography/tandem mass spectrometry

    Rapid Communications in Mass Spectrometry

    Volume 15, Issue 4, 28 February 2001, Pages: 297–303, R. S. Plumb, H. Warwick, D. Higton, G. J. Dear and D. N. Mallett

    Article first published online : 30 JAN 2001, DOI: 10.1002/rcm.225